1. Home
  2. PMCB vs ASTC Comparison

PMCB vs ASTC Comparison

Compare PMCB & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • ASTC
  • Stock Information
  • Founded
  • PMCB 1996
  • ASTC 1984
  • Country
  • PMCB United States
  • ASTC United States
  • Employees
  • PMCB N/A
  • ASTC N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PMCB Health Care
  • ASTC Industrials
  • Exchange
  • PMCB Nasdaq
  • ASTC Nasdaq
  • Market Cap
  • PMCB 11.4M
  • ASTC 11.0M
  • IPO Year
  • PMCB N/A
  • ASTC 1995
  • Fundamental
  • Price
  • PMCB $1.22
  • ASTC $5.91
  • Analyst Decision
  • PMCB
  • ASTC
  • Analyst Count
  • PMCB 0
  • ASTC 0
  • Target Price
  • PMCB N/A
  • ASTC N/A
  • AVG Volume (30 Days)
  • PMCB 14.5K
  • ASTC 2.8K
  • Earning Date
  • PMCB 03-17-2025
  • ASTC 05-12-2025
  • Dividend Yield
  • PMCB N/A
  • ASTC N/A
  • EPS Growth
  • PMCB N/A
  • ASTC N/A
  • EPS
  • PMCB 1.29
  • ASTC N/A
  • Revenue
  • PMCB N/A
  • ASTC $419,000.00
  • Revenue This Year
  • PMCB N/A
  • ASTC N/A
  • Revenue Next Year
  • PMCB N/A
  • ASTC N/A
  • P/E Ratio
  • PMCB $0.93
  • ASTC N/A
  • Revenue Growth
  • PMCB N/A
  • ASTC N/A
  • 52 Week Low
  • PMCB $1.03
  • ASTC $5.74
  • 52 Week High
  • PMCB $2.42
  • ASTC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 43.93
  • ASTC 41.25
  • Support Level
  • PMCB $1.15
  • ASTC $5.87
  • Resistance Level
  • PMCB $1.32
  • ASTC $6.09
  • Average True Range (ATR)
  • PMCB 0.11
  • ASTC 0.18
  • MACD
  • PMCB 0.02
  • ASTC 0.00
  • Stochastic Oscillator
  • PMCB 65.52
  • ASTC 23.94

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: